MSC Appoints Dallas Dunkley as VP of Business Development

July 26, 2019

Toronto, ON — Molecular Science Corp. (“MSC” or the “Company”) is pleased to provide an update on its leadership team as the Company continues to expand operations to support its rapid growth.

MSC has appointed Dallas Dunkley as Vice President of Business Development. Dallas will oversee MSC’s business development and certain strategic initiatives that will drive the continued growth of the company.

Dallas has over 25 years of combined sales and business development experience in the pharmaceutical industry and most recently in medical cannabis where, for the last year, Dallas held the role of Vice President of Business Development Medical at Terrascend and its Medical subsidiary Solace Health.

“The MSC team is excited to have Dallas on board. With his extensive experience in the cannabis and pharmaceutical sectors, he will play a key role in growing MSC’s business and supporting the company’s emergence as a leader in cannabis science for the medical segment”, said Christian Carswell, CEO of MSC.

The MSC board of directors, CEO Christian Carswell, CFO Jack Tasse and the entire MSC team welcome Dallas to the team as they look towards the Company’s next phase of growth.


Investor Relations


Phone 416-800-0479

About Molecular Science Corp.

Molecular Science Corp (MSC) is a leading analytical science and services company focused on cannabis and cannabis-derived products. MSC operates a state-of-the-art central laboratory under a CTLS Analytical Testing Licence, and a mobile laboratory that can be deployed to cultivation and manufacturing sites across Canada. MSC develops robust test methods for unique cannabis varieties and specific compounds of interest (e.g., cannabinoids, terpenes, toxins, etc.) in a range of product formats, including flower, oils, resins, topicals, edibles and beverages.